Skip to main content
Springer Nature Link
Log in

Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies

  • Letter to the Editors
  • Published:
Journal of Neurology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Canada)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098

    Article  PubMed  CAS  Google Scholar 

  2. Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36

    Article  PubMed  CAS  Google Scholar 

  3. Graus F, Saiz A, Dalmau J Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 257:509–517

  4. Iizuka T, Sakai F, Ide T, Monzen T, Yoshii S, Iigaya M, Suzuki K, Lynch DR, Suzuki N, Hata T, Dalmau J (2008) Anti-NMDA receptor encephalitis in Japan: long-term outcome without tumor removal. Neurology 70:504–511

    Article  PubMed  CAS  Google Scholar 

  5. Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667

Download references

Conflict of interest

Dr. Alexopoulos reports no conflict of interest. Dr. Kosmidis reports no conflict of interest. Dr. Dalmau receives research support from Euroimmun and the NIH/NCI (RO1CA107192 [PI] and RO1CA89054-06A2 [PI]); has received license fee payments from Euroimmun for a patent re: NMDA receptor autoantibody test; and has received royalty payments and may accrue revenue for a patent re: Ma2 autoantibody test. Dr. Dalakas reports no conflict of interest.

Author information

Authors and Affiliations

  1. Neuroimmunology Unit, Department of Pathophysiology, Faculty of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias St, 11527, Athens, Greece

    Harry Alexopoulos, Michalis L. Kosmidis & Marinos C. Dalakas

  2. University of Pennsylvania Medical Center, Philadelphia, PA, USA

    Josep Dalmau

Authors
  1. Harry Alexopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Michalis L. Kosmidis
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Josep Dalmau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marinos C. Dalakas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marinos C. Dalakas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alexopoulos, H., Kosmidis, M.L., Dalmau, J. et al. Paraneoplastic anti-NMDAR encephalitis: long term follow-up reveals persistent serum antibodies. J Neurol 258, 1568–1570 (2011). https://doi.org/10.1007/s00415-011-5982-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00415-011-5982-4

Keywords

Search

Navigation